Search

Search Constraints

You searched for: Author/Creator Reynes, Jacques

Search Results

11. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Issue 10107 (4th November 2017)

12. Comparative typing analyses of clinical and environmental strains of theCryptococcus neoformans/Cryptococcus gattiispecies complex from Ivory Coast. Issue 1 (January 2018)

13. Comparison of EBV DNA viral load in whole blood, plasma, B‐cells and B‐cell culture supernatant. Issue 5 (22nd November 2013)

14. Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case report. (2022)

15. Cryptococcus neoformansisolates from Yaoundé human immunodeficiency virus‐infected patients exhibited intra‐individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient. Issue 7 (July 2016)

16. Cystatin C in addition to creatinine for better assessment of glomerular renal function decline in people with HIV receiving antiretroviral therapy. (1st March 2023)

17. Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial). (24th February 2021)

18. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients – "En route for eradication"?. Issue 3 (September 2017)

19. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Issue 10 (October 2020)

20. Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting. (15th October 2021)